PTE Nasdaq 2020 - 12 - 22

PolarityTE, Inc.

PTE | $0.241 -0.82% -6.68% 0

(0.0% 1d) (0.0% 1m) (-48.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (261.85% volume)
Earnings Calendar: 2023-03-29
Market Cap: $ 1,777,672
http://www.polarityte.com
Sec Filling | Patents | 157 employees

(US) PolarityTE, Inc. is a biotechnology company developing and commercializing regenerative tissue products and biomaterials. The firm products include SkinTE Cryo, SkinTE POC, PTE 11000, OsteoTE and Real Time Assistant. Its SkinTE product is commercially available for the repair, reconstruction, replacement, and supplementation of skin in patients who have a need for treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. The company was founded on May 8, 1998 and is headquartered in Salt Lake City, UT.

skin cryo treatment

add to watch list Paper trade email alert is off

Press-releases

Insights into the Global Autologous Wound Patches Market: Drivers, Restraints, Opportunities and Challenges 2023 to 2030
Published: 2023-08-16 (Crawled : 16:00) - prnewswire.com
PTE | $0.241 -0.82% -6.68% 0

Consumer Durables

| Email alert Add to watchlist
AURX 4 | $0.95 116.67% 1K

| Email alert Add to watchlist
global

Delisting of Securities of Puhui Wealth Investment Management Co., Ltd.; National Energy Services Reunited Corp.; Bed Bath & Beyond Inc.; IMV Inc.; Celyad Oncology SA; Aptinyx Inc.; Athenex, Inc.; Greencity Acquisition Corporation; QualTek Services Inc.; Bellicum Pharmaceuticals, Inc.; Wejo Group Limited; Cyxtera Technologies, Inc.; HTG Molecular Diagnostics, Inc.; Unico American Corporation; PolarityTE, Inc.; Oncorus, Inc.; and OncoSec Medical Incorporated from The Nasdaq Stock Market
Published: 2023-07-06 (Crawled : 20:00) - globenewswire.com
ONCSQ | $0.0001 43900.0% 820

Manufacturing

| -99.89% | O: -15.79% H: 12.5% C: -6.25%
CYXTQ | $0.0007 -57.14% 1.8K

| -98.71% | O: -4.89% H: 17.73% C: -5.28%
QTEKQ | $0.012 125.0% 640K

Construction

| -36.36% | O: -17.88% H: 11.07% C: -0.37%
ATNXQ | $0.0152 -85.53% 3.6K

Manufacturing

| -86.19% | O: 54.31% H: 0.0% C: -29.37%
IMVIQ | $0.0001 36400.0% 6K

Manufacturing

| -100.0% | O: -18.75% H: 192.31% C: 32.62%
ONCR | $0.126 -75.95% 140K

Health Technology

| 196.13% | O: -2.05% H: 29.3% C: 0.0%
NESR | $9.0 500K

Industrial Services

| 198.33% | O: 0.0% H: 0.0% C: 0.0%
NDAQ | $60.285 0.36% 440K

Finance

| 22.49% | O: -0.22% H: 0.8% C: 0.18%
BLCM | $0.0748 381.28% 6.1K

Health Technology

| -79.78% | O: -14.11% H: 7.11% C: 6.2%
management nasdaq energy services beyond group acquisition medical molecular market

PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-10 (Crawled : 22:00) - prnewswire.com
PTE | $0.241 -0.82% -6.68% 0

Consumer Durables

| Email alert Add to watchlist
financial update results

PolarityTE to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022
Published: 2022-09-13 (Crawled : 13:20) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0

Consumer Durables

| -74.0% | O: 0.35% H: 13.98% C: 8.06%
global conference

PolarityTE to Report Q2 2022 Financial Results on August 11, 2022
Published: 2022-08-01 (Crawled : 14:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0

Consumer Durables